JP2021523895A5 - - Google Patents

Info

Publication number
JP2021523895A5
JP2021523895A5 JP2020562128A JP2020562128A JP2021523895A5 JP 2021523895 A5 JP2021523895 A5 JP 2021523895A5 JP 2020562128 A JP2020562128 A JP 2020562128A JP 2020562128 A JP2020562128 A JP 2020562128A JP 2021523895 A5 JP2021523895 A5 JP 2021523895A5
Authority
JP
Japan
Prior art keywords
composition
use according
bacterial strain
sequence
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020562128A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523895A (ja
Filing date
Publication date
Priority claimed from GBGB1810386.1A external-priority patent/GB201810386D0/en
Priority claimed from GBGB1813460.1A external-priority patent/GB201813460D0/en
Priority claimed from GBGB1817642.0A external-priority patent/GB201817642D0/en
Priority claimed from GBGB1820256.4A external-priority patent/GB201820256D0/en
Priority claimed from GBGB1820264.8A external-priority patent/GB201820264D0/en
Application filed filed Critical
Priority claimed from PCT/EP2019/062236 external-priority patent/WO2019215345A1/en
Publication of JP2021523895A publication Critical patent/JP2021523895A/ja
Publication of JP2021523895A5 publication Critical patent/JP2021523895A5/ja
Pending legal-status Critical Current

Links

JP2020562128A 2018-05-11 2019-05-13 細菌株を含む組成物 Pending JP2021523895A (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
EP18171893.3 2018-05-11
EP18171893 2018-05-11
EP18178136.0 2018-06-15
EP18178136 2018-06-15
GBGB1810386.1A GB201810386D0 (en) 2018-06-25 2018-06-25 Compositions comprising bacterial strains
GB1810386.1 2018-06-25
GB1813460.1 2018-08-17
GBGB1813460.1A GB201813460D0 (en) 2018-08-17 2018-08-17 Compositions comprising bacterial strains
GBGB1817642.0A GB201817642D0 (en) 2018-10-29 2018-10-29 Compositions comprising bacterial strains
GB1817642.0 2018-10-29
GBGB1820256.4A GB201820256D0 (en) 2018-12-12 2018-12-12 Compositions comprising bacterial strains
GBGB1820264.8A GB201820264D0 (en) 2018-12-12 2018-12-12 Compositions comprising bacterial strains
GB1820264.8 2018-12-12
GB1820256.4 2018-12-12
PCT/EP2019/062236 WO2019215345A1 (en) 2018-05-11 2019-05-13 Compositions comprising bacterial strains

Publications (2)

Publication Number Publication Date
JP2021523895A JP2021523895A (ja) 2021-09-09
JP2021523895A5 true JP2021523895A5 (enExample) 2022-05-20

Family

ID=66597549

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020545563A Expired - Fee Related JP7058449B2 (ja) 2018-05-11 2019-05-13 細菌株を含む組成物
JP2020562128A Pending JP2021523895A (ja) 2018-05-11 2019-05-13 細菌株を含む組成物
JP2022062741A Pending JP2022088631A (ja) 2018-05-11 2022-04-05 細菌株を含む組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020545563A Expired - Fee Related JP7058449B2 (ja) 2018-05-11 2019-05-13 細菌株を含む組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022062741A Pending JP2022088631A (ja) 2018-05-11 2022-04-05 細菌株を含む組成物

Country Status (23)

Country Link
US (3) US11419902B2 (enExample)
EP (4) EP4056192A1 (enExample)
JP (3) JP7058449B2 (enExample)
KR (2) KR20210008391A (enExample)
CN (2) CN112512539A (enExample)
AU (3) AU2019267170A1 (enExample)
BR (1) BR112020022833A2 (enExample)
CA (2) CA3098971A1 (enExample)
CY (1) CY1125211T1 (enExample)
DK (1) DK3743086T3 (enExample)
ES (1) ES2916601T3 (enExample)
HR (1) HRP20220578T1 (enExample)
IL (1) IL278471B2 (enExample)
LT (1) LT3743086T (enExample)
MD (1) MD3743086T2 (enExample)
MX (1) MX2020012061A (enExample)
PL (1) PL3743086T3 (enExample)
RS (1) RS63273B1 (enExample)
SG (2) SG11202011028SA (enExample)
SI (1) SI3743086T1 (enExample)
SM (1) SMT202200217T1 (enExample)
TW (2) TW202014513A (enExample)
WO (2) WO2019215345A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019009071A (es) 2017-01-31 2019-11-12 Univ Kansas State Celulas microbianas, metodos para producir las mismas, y usos de las mismas.
SMT202000555T1 (it) 2017-06-14 2020-11-10 4D Pharma Res Limited Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
EP3697220A4 (en) 2017-10-20 2021-08-11 MS Biotech, Inc. PROCESS FOR PRODUCING SILAGED PLANT MATERIAL USING MEGASPHAERA ELSDENII
PL3743086T3 (pl) 2018-05-11 2022-06-20 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
JP2022511975A (ja) * 2018-12-12 2022-02-01 フォーディー ファーマ リサーチ リミテッド 細菌株を含む組成物
TW202038979A (zh) * 2018-12-12 2020-11-01 英商4D製藥研究有限公司 包含細菌菌株之組成物
WO2021252861A1 (en) * 2020-06-11 2021-12-16 Evelo Biosciences, Inc. Compositions and methods for treating diseases and disorders using megasphaera sp
CN112877275B (zh) * 2021-02-04 2023-03-31 中国农业科学院兰州兽医研究所 Hdac2基因敲除的bhk-21细胞系及其构建方法和应用
CN112980878B (zh) * 2021-02-04 2023-03-31 中国农业科学院兰州兽医研究所 Hdac8基因敲除的bhk-21细胞系及其构建方法和应用
EP4520816A1 (en) 2022-04-28 2025-03-12 Moon (Guangzhou) Biotech Co., Ltd. Pharmaceutical composition, megasphaera, and use thereof
EP4516892A1 (en) 2022-04-28 2025-03-05 Moon (Guangzhou) Biotech Co., Ltd. Pharmaceutical composition, megasphaera, and use thereof
KR102551061B1 (ko) * 2022-05-26 2023-07-03 중앙대학교 산학협력단 Saha를 유효성분으로 포함하는 살모넬라 속 균주에 의한 바이오필름 생성 저해용 조성물
CN117018036B (zh) * 2023-07-28 2025-09-05 深圳未知君生物科技有限公司 巨球形菌属细菌在制备治疗癌症的药物中的应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5557520A (en) * 1978-10-26 1980-04-28 Nisshin Flour Milling Co Ltd Preparation of carcinostatic substance
EP1389464A4 (en) 2001-04-06 2005-06-22 Combi Co COMPOSITIONS WITH A BACTERIUM THAT MAY CONVERT MILKYLIC ACID TO BUTTERIC ACID, AND METHOD FOR THE PREVENTION / TREATMENT OF HYPERLACTACIDEMIA IN CARCINOMA IN DIGESTIVE TRAIN AND COLON USING THESE COMPOSITIONS
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
US20040005304A1 (en) 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
GB0307026D0 (en) * 2003-03-27 2003-04-30 Rowett Res Inst Bacterial supplement
CN102349927A (zh) 2003-08-29 2012-02-15 Hdac默克研究有限责任公司 联合治疗癌症的方法
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
SG11201503966PA (en) 2012-11-23 2015-06-29 Seres Health Inc Synergistic bacterial compositions and methods of production and use thereof
US10973861B2 (en) 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
WO2015010096A1 (en) * 2013-07-18 2015-01-22 Baylor College Of Medicine Method of enhancing potency of immune cells
CN104415060A (zh) * 2013-08-30 2015-03-18 深圳华大基因科技有限公司 可食用组合物及其制备方法和用途
US10203329B2 (en) * 2013-09-12 2019-02-12 The Johns Hopkins University Biofilm formation to define risk for colon cancer
CN105979952B (zh) 2013-11-25 2022-04-08 赛里斯治疗公司 协同细菌组合物以及其制造方法和用途
US9650654B2 (en) * 2014-06-25 2017-05-16 William Marsh Rice University Making C4+ products in bacteria
US10366793B2 (en) * 2014-10-21 2019-07-30 uBiome, Inc. Method and system for characterizing microorganism-related conditions
WO2016073381A1 (en) * 2014-11-03 2016-05-12 Cerus Corporation Compositions and methods for improved car-t cell therapies
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10231941B2 (en) * 2015-01-23 2019-03-19 Temple University—Of The Commonwealth System of Higher Educaton Use of short chain fatty acids in cancer prevention
WO2016149449A1 (en) 2015-03-18 2016-09-22 Tufts University Compositions and methods for preventing colorectal cancer
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN108513545B (zh) * 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
PL3380108T3 (pl) * 2015-11-24 2023-03-27 Seres Therapeutics, Inc. Zaprojektowane kompozycje bakteryjne
WO2017122197A1 (en) * 2016-01-11 2017-07-20 3Plw Ltd. Lactic acid-utilizing bacteria genetically modified to secrete polysaccharide-degrading enzymes
CN107028985A (zh) * 2016-02-04 2017-08-11 深圳华大基因研究院 厚壁菌类益生菌在预防和/或治疗糖尿病及其相关疾病中的应用
WO2017172894A2 (en) * 2016-03-30 2017-10-05 The Trustees Of Columbia University In The City Of New York Methods of preventing, treating and detecting colorectal cancer using butyrate producing bacteria
US9999641B2 (en) * 2016-06-14 2018-06-19 Vedanta Biosciences, Inc. Treatment of clostridium difficile infection
KR102708641B1 (ko) * 2016-09-27 2024-09-24 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 미생물유전체를 조정함으로써 면역 체크포인트 차단 요법을 증강시키는 방법
WO2018094190A2 (en) 2016-11-18 2018-05-24 Sanford Burnham Prebys Medical Discovery Institute Gut microbiota and treatment of cancer
US20190314427A1 (en) 2016-12-16 2019-10-17 Evelo Biosciences, Inc. Methods of treating cancer using parabacteroides
WO2018112365A2 (en) 2016-12-16 2018-06-21 Evelo Biosciences, Inc. Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii
CA3066189A1 (en) * 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
SMT202000555T1 (it) * 2017-06-14 2020-11-10 4D Pharma Res Limited Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
PL3743086T3 (pl) * 2018-05-11 2022-06-20 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
TW202038979A (zh) 2018-12-12 2020-11-01 英商4D製藥研究有限公司 包含細菌菌株之組成物
JP2022511975A (ja) * 2018-12-12 2022-02-01 フォーディー ファーマ リサーチ リミテッド 細菌株を含む組成物

Similar Documents

Publication Publication Date Title
JP2021523895A5 (enExample)
JP2018199695A5 (enExample)
Chua et al. Designer probiotics for the prevention and treatment of human diseases
JP2022088631A5 (enExample)
Górska et al. Probiotic Bacteria: A Promising Tool in Cancer Prevention and Therapy: A. Górska et al.
JP2019001815A5 (enExample)
RU2020132171A (ru) Новая бифидобактерия, характеризующаяся различными функциями, и ее применение
Mirza et al. Efficacy of Bacillus clausii UBBC-07 spores in the amelioration of oral mucositis in head and neck cancer patients undergoing radiation therapy
HRP20220578T1 (hr) Pripravci koji sadrže bakterijske sojeve
JP2022003086A5 (enExample)
Corr et al. Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens
Hu et al. Anti-tumour immune effect of oral administration of Lactobacillus plantarum to CT26 tumour-bearing mice
JP2019522649A5 (enExample)
HRP20191344T1 (hr) Sastavi koji sadrže bakterijske sojeve
Abedin-Do et al. Immunomodulatory effects of Lactobacillus strains: emphasis on their effects on cancer cells
JP2019517828A5 (enExample)
Panebianco et al. Microbiota manipulation by probiotics administration as emerging tool in cancer prevention and therapy
JP2022540186A (ja) ビフィドバクテリウム・ビフィダム菌株、その組成物及び関連用途
JP2021518414A5 (enExample)
Sharma et al. Role of probiotics in the management of lung cancer and related diseases: An update
US10660923B2 (en) Sinusitis diagnostics and treatments
Sim et al. The ameliorative role of probiotics in 5-fluorouracil induced intestinal mucositis
HK1206246A1 (en) Use of high dose laquinimod for treating multiple sclerosis
Ashique et al. It is all about probiotics to control cervical cancer
Mandal et al. Isolation and characterization of lactobacilli from human faeces and indigenous fermented foods for their potential application as probiotics